SCHEMBL20801733

SCHEMBL20801733

CC(C)[C@H](C)c1ccc2c(c1)CCC(=O)N2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 4/20 0.52
KCNH2 Q12809 5/20 0.50
PDE3B Q13370 4/20 0.50
PDE3A Q14432 4/20 0.50
TBXAS1 P24557 3/20 0.50
NPC1 O15118 2/20 0.47
MAPK13 O15264 1/20 0.47
MAPK12 P53778 1/20 0.47
MAPK11 Q15759 1/20 0.47
MAPK14 Q16539 1/20 0.47
CA9 Q16790 1/20 0.46
MAPT P10636 1/20 0.44
MMP12 P39900 1/20 0.44
RAB9A P51151 1/20 0.44
CYP1A2 P05177 2/20 0.43
CYP11B1 P15538 2/20 0.43
CYP11B2 P19099 2/20 0.43
CYP2C9 P11712 1/20 0.43
CRBN Q96SW2 1/20 0.43
PKM P14618 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22184244 1.00 KIF11 (0.52) KIF11KCNH2PDE3BPDE3ATBXAS1
SCHEMBL2611074 0.87 KIF11 (0.66) KIF11KCNH2PDE3BPDE3ATBXAS1
SCHEMBL9148322 0.86 KCNH2 (0.58) KIF11KCNH2PDE3BPDE3ATBXAS1
SCHEMBL21983115 0.85 AHR (0.53) PDE3BPDE3ACYP1A2CYP11B1CYP11B2
SCHEMBL8917088 0.84 KCNH2 (0.53) KIF11KCNH2PDE3BPDE3ATBXAS1
SCHEMBL9485923 0.84 KIF11 (0.52) KIF11KCNH2PDE3BPDE3ATBXAS1
Hydrochloric Acid SCHEMBL8917748 0.83 KIF11 (0.51) KIF11KCNH2PDE3BPDE3ATBXAS1
SCHEMBL12995265 0.81 KIF11 (0.50) KIF11KCNH2PDE3BPDE3ATBXAS1
SCHEMBL11574095 0.80 KIF11 (0.52) KIF11KCNH2PDE3BPDE3ATBXAS1
SCHEMBL18500396 0.79 TBXAS1 (0.54) KIF11KCNH2PDE3BPDE3ATBXAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190077762-A1 QUINOLONE COMPOUND OTSUKA PHARMA CO LTD (JP) 2019-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190077762-A1 QUINOLONE COMPOUND HAX1, NQO2, NHERF1 KIF11 1498/4885KCNH2 38/4885PDE3B 1731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.